The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Facing depression with botulinum toxin: A randomized controlled trial
Open accessAbstract
Positive effects on mood have been observed in subjects who underwent treatment of glabellar frown lines with botulinum toxin and, in an open case series, depression remitted or improved after such treatment. Using a randomized double-blind placebo-controlled trial design we assessed botulinum toxin injection to the glabellar region as an adjunctive treatment of major depression. Thirty patients were randomly assigned to a verum (onabotulinumtoxinA, n = 15) or placebo (saline, n = 15) group. The primary end point was change in the 17-item version of the Hamilton Depression Rating Scale six weeks after treatment compared to baseline. The verum and the placebo groups did not differ significantly in any of the collected baseline characteristics. Throughout the sixteen-week follow-up period there was a significant improvement in depressive symptoms in the verum group compared to the placebo group as measured by the Hamilton Depression Rating Scale (F((6,168)) = 5.76, p < 0.001, η(2) = 0.17). Six weeks after a single treatment scores of onabotulinumtoxinA recipients were reduced on average by 47.1% and by 9.2% in placebo-treated participants (F((1,28)) = 12.30, p = 0.002, η(2) = 0.31, d = 1.28). The effect size was even larger at the end of the study (d = 1.80). Treatment-dependent clinical improvement was also reflected in the Beck Depression Inventory, and in the Clinical Global Impressions Scale. This study shows that a single treatment of the glabellar region with botulinum toxin may shortly accomplish a strong and sustained alleviation of depression in patients, who did not improve sufficiently on previous medication. It supports the concept, that the facial musculature not only expresses, but also regulates mood states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
James, W. (1913) · Henry Holt and Company eBooks · doi:10.1037/11059-000 · Cited by 25,226
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 1×
“The effect sizes in our study were large and the response and remission rates were high for a trial with patients suffering from partly chronic and treatment resistant depression (Rush et al., 2006).”
BackgroundPsychometric properties of the credibility/expectancy questionnaire
Devilly, G. J., & Borkovec, T. D. (2000) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(00)00012-4 · Cited by 2,295
Strack, F., Martin, L. L., & Stepper, S. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.5.768 · Cited by 1,898
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994
Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900 · cited 1×
“However, high unblinding rates are common in antidepressant trials and a recent study shows that open-label placebo treatment can still induce clinical improvement (Perlis et al., 2010; Even et al., 2000; Kaptchuk et al., 2010).”
BackgroundDEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
(1997) · PubMed · Cited by 727
Assessment of blinding in clinical trials
Bang, H., Ni, L., & Davis, C. E. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2003.10.016 · Cited by 682
The Expression of Emotion in Man and Animals
Darwin, C. D. (2020) · Cited by 649
Treatment of Glabellar Frown Lines with C. Botulinum‐A Exotoxin
CARRUTHERS, J. D. A., & CARRUTHERS, J. A. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb03295.x · Cited by 612
Long-Distance Retrograde Effects of Botulinum Neurotoxin A
Antonucci, F., Rossi, C., Gianfranceschi, L., Rossetto, O., & Caleo, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0375-08.2008 · Cited by 450
Treatment of Glabellar Frown Lines with C. Botulinum-A Exotoxin
Ramesh, S. (2022) · Foundational Papers in Oculoplastics · doi:10.1007/978-3-030-92794-3_9 · Cited by 434
Facial Muscle Patterning to Affective Imagery in Depressed and Nondepressed Subjects
Schwartz, G. E., Fair, P. L., Salt, P., Mandel, M. R., & Klerman, G. L. (1976) · Science · doi:10.1126/science.1257786 · Cited by 430
Cosmetic Use of Botulinum Toxin-A Affects Processing of Emotional Language
Havas, D. A., Glenberg, A. M., Gutowski, K. A., Lucarelli, M. J., & Davidson, R. J. (2010) · Psychological Science · doi:10.1177/0956797610374742 · Cited by 389
Meta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346
Neal, D. T., & Chartrand, T. L. (2011) · Social Psychological and Personality Science · doi:10.1177/1948550611406138 · Cited by 293
Hennenlotter, A., Dresel, C., Castrop, F., Ceballos-Baumann, A. O., Wohlschläger, A. M., & Haslinger, B. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn104 · Cited by 269
The Effects of BOTOX Injections on Emotional Experience
Davis, J. I., Senghas, A., Brandt, F., & Ochsner, K. N. (2010) · Emotion · doi:10.1037/a0018690 · Cited by 258 · cited 1×
“Treatment of the glabellar region with botulinum toxin produces a relative change in facial expression from angry, sad, and fearful to happy and can impact on emotional experience (Heckmann et al., 2003; Davis et al., 2010).”
BackgroundFactors associated with chronic depressive episodes: a preliminary report from the STAR‐D project
Gilmer, W. S., Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Luther, J., Howland, R. H., Yohanna, D., Khan, A., & Alpert, J. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00633.x · Cited by 181
Treatment of Depression with Botulinum Toxin A: A Case Series
FINZI, E., & WASSERMAN, E. (2006) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2006.32136.x · Cited by 181
Larsen, R. J., Kasimatis, M., & Frey, K. (1992) · Cognition and Emotion · doi:10.1080/02699939208409689 · Cited by 180
Brunoni, A. R., Lopes, M., Kaptchuk, T. J., & Fregni, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004824 · Cited by 173
Botulinum toxin cosmetic therapy correlates with a more positive mood
Lewis, M. B., & Bowler, P. J. (2009) · Journal of Cosmetic Dermatology · doi:10.1111/j.1473-2165.2009.00419.x · Cited by 154
Brin, M. F., Boodhoo, T., Pogoda, J. M., James, L. M., Demos, G., Terashima, Y., Gu, J., Eadie, N., & Bowen, B. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.06.040 · Cited by 134
Reproducibility of a four-point clinical severity score for glabellar frown lines
Honeck, P. R., Weiss, C., Sterry, W., Rzany, B., & for the Gladys study group (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05436.x · Cited by 100
Clinical features of depressed patients who do and do not improve with placebo
Brown, W. A., Johnson, M. F. K., & Chen, M.-G. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90002-k · Cited by 99
Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription database
Serna, M. C., Cruz, I., Real, J., Eguíluz, E. G., & Galván, L. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.07.012 · Cited by 98
Heckmann, M., Teichmann, B., Schröder, U., Sprengelmeyer, R., & Ceballos-Baumann, A. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)00909-5 · Cited by 69
Jf, G., Genero, N. P., & Hl, P. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.3.348 · Cited by 59
Assuring That Double-Blind Is Blind
Perlis, R. H., Ostacher, M. J., D, M. F. M., Nierenberg, A. A., Sachs, G. S., & Rosenbaum, J. F. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09060820 · Cited by 51
Critical approach to antidepressant trials
EVEN, C., Siobud-Dorocant, E., & Dardennes, R. M. (2000) · The British Journal of Psychiatry · doi:10.1192/bjp.177.1.47 · Cited by 48
Cited by
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Pirazzini, M., Rossetto, O., Eleopra, R., & Montecucco, C. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.012658 · Cited by 768
Embodied affectivity: on moving and being moved
Fuchs, T., & Koch, S. C. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00508 · Cited by 399
Fashioning the face: sensorimotor simulation contributes to facial expression recognition
Wood, A., Rychlowska, M., Korb, S., & Niedenthal, P. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.12.010 · Cited by 353
Osypiuk, K., Thompson, E., & Wayne, P. M. (2018) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2018.00174 · Cited by 61
“…placebo controlled trial, individuals with treatment-resistant depression showed improvement in their depression symptoms within 6 weeks of receiving Botox injections in the muscles of the glabellar region, which are associated with expression of negative emotion (Wollmer et al., 2012).”
BackgroundSarwer, D. B., Spitzer, J. C., Sobanko, J. F., & Beer, K. R. (2015) · Dermatologic Surgery · doi:10.1097/dss.0000000000000279 · Cited by 30
Metadata
- Authors
- Wollmer, M. A., de Boer, C., Kalak, N., Beck, J., Götz, T., Schmidt, T., Hodzic, M., Bayer, U., Kollmann, T., Kollewe, K., Sönmez, D., Duntsch, K., Haug, M. D., Schedlowski, M., Hatzinger, M., Dressler, D., Brand, S., Holsboer-Trachsler, E., & Kruger, T. H. C.
- Venue
- Journal of Psychiatric Research
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 46
- Issue
- 5
- Pages
- 574-581
- ISSN
- 0022-3956 (ISSN-L)
- OpenAlex
- W1979284255
- Cited by
- 278
- References
- 32
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.